
A New Era in Alzheimer's Disease Detection: Nepal's First Plasma p-Tau217 / β-Amyloid 1-42 Ratio Test
Life Quest Clinical Lab is launching Nepal's first Plasma p-Tau217 / β-Amyloid 1-42 Ratio assay — an advanced blood-based biomarker for Alzheimer's disease evaluation. Coming August 2026.
Read article







